Quarterly Result14 May 2026, 05:31 pm
Venmax Drugs: FY26 Revenue at ₹802.49 Lakhs
AI Summary
Venmax Drugs and Pharmaceuticals Ltd declared audited financial results for the quarter and year ended March 31, 2026. The company's revenue from operations for the year ended March 31, 2026, stood at ₹802.49 lakhs, compared to ₹80.73 lakhs in the previous year. The company reported a profit of ₹24.82 lakhs for the year ended March 31, 2026, compared to a loss of ₹1.05 lakhs in the previous year.
Key Highlights
- Revenue from operations for FY26 reached ₹802.49 lakhs.
- The company reported a profit of ₹24.82 lakhs for FY26.
- 63,44,000 share warrants were converted into equity shares during the year.
- Auditors issued an unmodified opinion on the standalone financial results.
Price Impact
More from VENMAX